TLC is creating a pipeline of new therapies to treat blood cancers using less traditional forms of drug discovery and development. (cancerres.aacrjournals.org)
Studies conducted in China and the United States demonstrated that arsenic — long considered a carcinogen — helps treat a blood cancer called acute promyelocytic leukemia. (sciencemag.org)
Keith Brown, an epigenetics researcher at the University of Bristol, UK, says that de-methylating agents already treat some blood cancers successfully, but it is not clear how they work. (newscientist.com)